Across the past 12 months, open-market trades by Cognition Therapeutics insiders were all purchases, totaling $32,492 (29.18K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Lisa Ricciardi | Ceo President | 1,715,851 | 0 | 1,715,851 | 46.6% | 20 Apr, 2026 |
| 2 | Anthony Caggiano | Chief Medical Officer | 874,906 | 0 | 874,906 | 23.8% | 20 Apr, 2026 |
| 3 | John Brendan Doyle | Chief Financial Officer | 618,942 | 0 | 618,942 | 16.8% | 04 May, 2026 |
| 4 | Peggy Wallace | Director | 111,461 | 0 | 111,461 | 3.0% | 22 Jun, 2026 |
| 5 | Ellen B Richstone | Director | 83,500 | 0 | 83,500 | 2.3% | 22 Jun, 2026 |
| 6 | Aaron G.L. Fletcher | Director, TenPercentOwner | 81,229 | 0 | 81,229 | 2.2% | 22 Jun, 2026 |
| 7 | Jack A. Khattar | Director | 73,500 | 0 | 73,500 | 2.0% | 22 Jun, 2026 |
| 8 | Brett P Monia | Director | 73,500 | 0 | 73,500 | 2.0% | 22 Jun, 2026 |
| 9 | Leslie W. Kreis | Director, TenPercentOwner | 0 | 48,500 | 48,500 | 1.3% | 20 Jun, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 17 Jun, 2026 | Aaron G.L. Fletcher | Director, TenPercentOwner | Acquired A | 25,000 | $0.00 | $0 | 81,229 | Direct |
| 17 Jun, 2026 | Peggy Wallace | Director | Acquired A | 25,000 | $0.00 | $0 | 111,461 | Direct |
| 17 Jun, 2026 | Jack A. Khattar | Director | Acquired A | 25,000 | $0.00 | $0 | 73,500 | Direct |
| 17 Jun, 2026 | Ellen B Richstone | Director | Acquired A | 25,000 | $0.00 | $0 | 83,500 | Direct |
| 17 Jun, 2026 | Brett P Monia | Director | Acquired A | 25,000 | $0.00 | $0 | 73,500 | Direct |
| 01 May, 2026 | John Brendan Doyle | Chief Financial Officer | Disposed F | 8,567 | $1.28 | $10.97K | 618,942 | Direct |
| 16 Apr, 2026 | John Brendan Doyle | Chief Financial Officer | Acquired P | 10,000 | $1.13 | $11.30K | 627,509 | Direct |
| 16 Apr, 2026 | Lisa Ricciardi | Ceo President | Acquired P | 9,175 | $1.10 | $10.09K | 1,715,851 | Direct |
| 16 Apr, 2026 | Anthony Caggiano | Chief Medical Officer | Acquired P | 10,000 | $1.11 | $11.10K | 874,906 | Direct |
| 15 Feb, 2026 | Lisa Ricciardi | Ceo President | Disposed F | 5,850 | $1.12 | $6.55K | 1,706,676 | Direct |
| 15 Feb, 2026 | Anthony Caggiano | Chief Medical Officer | Disposed F | 4,680 | $1.12 | $5.24K | 864,906 | Direct |
| 15 Feb, 2026 | John Brendan Doyle | Chief Financial Officer | Disposed F | 1,560 | $1.12 | $1.75K | 617,509 | Direct |
| 03 Feb, 2026 | John Brendan Doyle | Chief Financial Officer | Acquired A | 200,000 | $0.00 | $0 | 645,990 | Direct |
| 03 Feb, 2026 | Anthony Caggiano | Chief Medical Officer | Acquired A | 400,000 | $0.00 | $0 | 907,993 | Direct |
| 03 Feb, 2026 | Lisa Ricciardi | Ceo President | Acquired A | 800,000 | $0.00 | $0 | 1,790,266 | Direct |
| 03 Feb, 2026 | Anthony Caggiano | Chief Medical Officer | Disposed F | 11,488 | $1.12 | $12.87K | 896,505 | Direct |
| 04 Feb, 2026 | John Brendan Doyle | Chief Financial Officer | Disposed F | 26,921 | $1.03 | $27.73K | 619,069 | Direct |
| 03 Feb, 2026 | Lisa Ricciardi | Ceo President | Disposed F | 26,036 | $1.12 | $29.16K | 1,764,230 | Direct |
| 04 Feb, 2026 | Anthony Caggiano | Chief Medical Officer | Disposed F | 26,919 | $1.03 | $27.73K | 869,586 | Direct |
| 04 Feb, 2026 | Lisa Ricciardi | Ceo President | Disposed F | 51,704 | $1.03 | $53.26K | 1,712,526 | Direct |